Medicine and Dentistry
Neoplasm
100%
Bladder Cancer
90%
Circulating Tumor DNA
67%
Disease
49%
Transitional Cell Carcinoma
46%
Muscle Invasive Bladder Cancer
42%
Colorectal Cancer
34%
Mutational Analysis
34%
Cystectomy
32%
Bladder Tumor
32%
Recurrent Disease
31%
Neoadjuvant Chemotherapy
28%
Combination Therapy
28%
Cisplatin
27%
Treatment Response
26%
RNA Sequence
23%
Biochemical Recurrence
22%
Prostate Cancer
22%
Prostatectomy
22%
DNA Methylation
22%
Caspase
22%
Tamsulosin
22%
microRNA
21%
Transcriptomics
16%
DNA Determination
16%
Metastatic Carcinoma
15%
Tumor Biopsy
15%
Primary Tumor
14%
Nuclear RNA
13%
Minimal Residual Disease
11%
Somatics
11%
Mir-145
11%
Disease Burden
11%
Cancer Surgery
11%
Liquid Biopsy
11%
Cell-Free DNA
11%
Urothelial Cancer
11%
T Cell Development
11%
Cancer Cell Line
11%
Cell Death
11%
Cell Cycle Arrest
11%
Cancer Cell
10%
Exome Sequencing
9%
Targeted Therapy
8%
Metastatic Bladder Cancer
8%
Diagnosis
8%
Somatic Mutation
8%
Specific Tumor
8%
First-Line Chemotherapy
7%
Risk Stratification
7%
Biochemistry, Genetics and Molecular Biology
MicroRNA
68%
Cancer Cell
49%
APOBEC
45%
Transcriptomics
34%
Single-Nucleotide Polymorphism
31%
Methylation
28%
Allele
28%
Cell Cycle
25%
Mesenchymal-Epithelial Transition
22%
Circulating Tumor DNA
22%
Gene Mutation
22%
Gene Expression Profiling
22%
Genomics
18%
Proteomics
18%
Subtyping
18%
Exome Sequencing
18%
Transcriptome
18%
Genotyping
17%
Immunocompetent Cell
17%
Genome Instability
17%
Microarrays
17%
Next Generation Sequencing
17%
Genome-Wide Association Study
17%
Tumor Volume
17%
RNA Sequence
15%
Binding Site
15%
Cell Infiltration
15%
Genetics
15%
Microsatellite DNA
14%
Transcription Factors
14%
Whole Genome Sequencing
14%
Mucosa
12%
Tumor-Related Gene
12%
Mir-145
12%
Mutagenic Activity
12%
Biological Phenomena and Functions Concerning the Entire Organism
12%
RNA
11%
Oncogene
11%
Supernatant
11%
Phylogeny
11%
E2F1
11%
Cell Cycle Arrest
11%
Clonality
11%
Germ Cell
11%
Caspase
11%
Cell Death
11%
Disease Burden
11%
Mutation Rate
11%
Enzyme
11%
Beta-Catenin
11%
Keyphrases
Tumor mutation Burden
15%
Tumor
15%
Mutational Analysis
11%
Patient-derived Spheroids
11%
Spheroid Culture
11%
Biological Analysis
11%
Advanced Urothelial Carcinoma
11%
Advanced Bladder Cancer
11%
Metastatic Relapse
11%
Bladder Cancer
11%
Field Cancerization
11%
DNA mutational Analysis
11%
Urine DNA
11%
Neoadjuvant Chemotherapy Response
11%
Chemotherapy Outcomes
11%
Urothelial Carcinoma
11%
Prostate Cancer
11%
Evolutionary Divergence
11%
Genetic Modification
11%
Divergence
11%
Urine Supernatant
8%
Nontumor
7%
Bladder
7%
